1. Home
  2. TGL vs GNPX Comparison

TGL vs GNPX Comparison

Compare TGL & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TGL

Treasure Global Inc.

HOLD

Current Price

$3.73

Market Cap

7.8M

Sector

Technology

ML Signal

HOLD

Logo Genprex Inc.

GNPX

Genprex Inc.

HOLD

Current Price

$1.90

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGL
GNPX
Founded
2020
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8M
6.4M
IPO Year
2022
2017

Fundamental Metrics

Financial Performance
Metric
TGL
GNPX
Price
$3.73
$1.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
24.6K
836.8K
Earning Date
02-24-2026
04-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
76.33
EPS
N/A
N/A
Revenue
$2,330,557.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.04
$0.14
52 Week High
$58.00
$12.97

Technical Indicators

Market Signals
Indicator
TGL
GNPX
Relative Strength Index (RSI) 37.05 43.37
Support Level $0.89 $1.88
Resistance Level $9.45 $2.51
Average True Range (ATR) 0.27 0.12
MACD -0.01 0.01
Stochastic Oscillator 5.74 21.50

Price Performance

Historical Comparison
TGL
GNPX

About TGL Treasure Global Inc.

Treasure Global Inc has created an online-to-offline e-commerce platform business model that offers consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retail or merchant settings. Its product is an internet application branded as the ZCITY app, which targets consumers by providing personalized deals based on their purchase history, location, and preferences. The Company has two reportable segments: payment processing and e-commerce operation in its ZCITY platform, and customized software development service, and the majority of revenue comes from payment processing and e-commerce operation in its ZCITY platform.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: